These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 16895839

  • 1. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms.
    Zhu Y, Mehta KA, McGinity JW.
    Pharm Dev Technol; 2006; 11(3):285-94. PubMed ID: 16895839
    [Abstract] [Full Text] [Related]

  • 2. Solid-state plasticization of an acrylic polymer with chlorpheniramine maleate and triethyl citrate.
    Zhu Y, Shah NH, Malick AW, Infeld MH, McGinity JW.
    Int J Pharm; 2002 Jul 25; 241(2):301-10. PubMed ID: 12100857
    [Abstract] [Full Text] [Related]

  • 3. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
    Zhu Y, Shah NH, Malick AW, Infeld MH, McGinity JW.
    Drug Dev Ind Pharm; 2006 Jun 25; 32(5):569-83. PubMed ID: 16720412
    [Abstract] [Full Text] [Related]

  • 4. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D, Zheng W, Coots LB, McGinity JW.
    Eur J Pharm Biopharm; 2007 Sep 25; 67(2):464-75. PubMed ID: 17451929
    [Abstract] [Full Text] [Related]

  • 5. Influence of methylparaben as a solid-state plasticizer on the physicochemical properties of Eudragit RS PO hot-melt extrudates.
    Wu C, McGinity JW.
    Eur J Pharm Biopharm; 2003 Jul 25; 56(1):95-100. PubMed ID: 12837487
    [Abstract] [Full Text] [Related]

  • 6. Citric acid as a solid-state plasticizer for Eudragit RS PO.
    Schilling SU, Shah NH, Malick AW, Infeld MH, McGinity JW.
    J Pharm Pharmacol; 2007 Nov 25; 59(11):1493-500. PubMed ID: 17976259
    [Abstract] [Full Text] [Related]

  • 7. Influence of thermal processing on the properties of chlorpheniramine maleate tablets containing an acrylic polymer.
    Zhu Y, Shah NH, Malick AW, Infeld MH, McGinity JW.
    Pharm Dev Technol; 2002 Nov 25; 7(4):481-9. PubMed ID: 12503529
    [Abstract] [Full Text] [Related]

  • 8. Properties of melt extruded enteric matrix pellets.
    Schilling SU, Shah NH, Waseem Malick A, McGinity JW.
    Eur J Pharm Biopharm; 2010 Feb 25; 74(2):352-61. PubMed ID: 19782133
    [Abstract] [Full Text] [Related]

  • 9. Influence of additives on melt viscosity, surface tension, and film formation of dry powder coatings.
    Sauer D, McGinity JW.
    Drug Dev Ind Pharm; 2009 Jun 25; 35(6):646-54. PubMed ID: 19337869
    [Abstract] [Full Text] [Related]

  • 10. Influence of plasticizer type and level on the properties of Eudragit S100 matrix pellets prepared by hot-melt extrusion.
    Schilling SU, Lirola HL, Shah NH, Waseem Malick A, McGinity JW.
    J Microencapsul; 2010 Jun 25; 27(6):521-32. PubMed ID: 20575612
    [Abstract] [Full Text] [Related]

  • 11. Crystal growth formation in melt extrudates.
    Bruce C, Fegely KA, Rajabi-Siahboomi AR, McGinity JW.
    Int J Pharm; 2007 Aug 16; 341(1-2):162-72. PubMed ID: 17524578
    [Abstract] [Full Text] [Related]

  • 12. Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer.
    Sawant KP, Fule R, Maniruzzaman M, Amin PD.
    Drug Deliv Transl Res; 2018 Dec 16; 8(6):1679-1693. PubMed ID: 29948916
    [Abstract] [Full Text] [Related]

  • 13. Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion.
    Roblegg E, Jäger E, Hodzic A, Koscher G, Mohr S, Zimmer A, Khinast J.
    Eur J Pharm Biopharm; 2011 Nov 16; 79(3):635-45. PubMed ID: 21801834
    [Abstract] [Full Text] [Related]

  • 14. Investigation of the drug release and surface morphological properties of film-coated pellets, and physical, thermal and mechanical properties of free films as a function of various curing conditions.
    Bhattacharjya S, Wurster DE.
    AAPS PharmSciTech; 2008 Nov 16; 9(2):449-57. PubMed ID: 18431665
    [Abstract] [Full Text] [Related]

  • 15. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H, McGinity JW.
    Int J Pharm; 2006 Oct 12; 323(1-2):11-7. PubMed ID: 16815652
    [Abstract] [Full Text] [Related]

  • 16. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.
    Dave VS, Fahmy RM, Bensley D, Hoag SW.
    Drug Dev Ind Pharm; 2012 Oct 12; 38(10):1240-53. PubMed ID: 22257339
    [Abstract] [Full Text] [Related]

  • 17. The manufacture and characterisation of hot-melt extruded enteric tablets.
    Andrews GP, Jones DS, Diak OA, McCoy CP, Watts AB, McGinity JW.
    Eur J Pharm Biopharm; 2008 May 12; 69(1):264-73. PubMed ID: 18164604
    [Abstract] [Full Text] [Related]

  • 18. Influence of film additives on stabilizing drug release rates from pellets coated with acrylic polymers.
    Maejima T, McGinity JW.
    Pharm Dev Technol; 2001 May 12; 6(2):211-21. PubMed ID: 11416995
    [Abstract] [Full Text] [Related]

  • 19. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU, Bruce CD, Shah NH, Malick AW, McGinity JW.
    Int J Pharm; 2008 Sep 01; 361(1-2):158-68. PubMed ID: 18582547
    [Abstract] [Full Text] [Related]

  • 20. Physicochemical properties of film-coated melt-extruded pellets.
    Young CR, Crowley M, Dietzsch C, McGinity JW.
    J Microencapsul; 2007 Feb 01; 24(1):57-71. PubMed ID: 17438942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.